Status:

RECRUITING

Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

Lead Sponsor:

The Filatov Institute of Eye Diseases and Tissue Therapy

Collaborating Sponsors:

CheckEye LLC

Oftacentro SA

Conditions:

Diabetic Retinopathy

Eligibility:

All Genders

18-90 years

Brief Summary

To examine the potential for the detection of diabetic retinopathy (DR) using the artificial intelligence (AI)-based software platform Retina-AI.

Detailed Description

Operator took fundus images with a non-mydriatic fundus camera as per the Retina-AI CheckEye imaging protocol (an optic disc centered image and a fovea centered image for each eye).Thereafter, operato...

Eligibility Criteria

Inclusion

  • Documented diagnosis of diabetes mellitus by definition.
  • Understanding of the Study and willingness and ability to sign informed consent
  • Patient age 18 or above
  • Diagnostic for diabetes: 4a) Type 1 diabetes of a lest 5 years of evolution; or 4b) Type 2 diabetes

Exclusion

  • Patients under 18 years of age; 2. Failure to give informed consent; 3. Presence of retinal diseases - acquired disease: age-related macular degeneration (AMD), occlusion of retinal vessels (ORV), etc.; birth defects: coloboma of choroid or optic nerve disc, etc.; hereditary diseases: retinitis pigmentosa, angioid streaks of the retina, etc.
  • 4\. A patient who has already undergone treatment (surgery, laser, etc.) for any disease of the retina: age-related macular degeneration (AMD), retinal vascular occlusion (ARV), etc. These patients should be excluded or allocated to a separate group.

Key Trial Info

Start Date :

November 2 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT06879834

Start Date

November 2 2024

End Date

December 1 2025

Last Update

March 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Filatov Institute of Eye Diseases and Tissue Therapy

Odesa, Ukraine, 65061